Atlas Trials

A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine

Clinical trial NCT04811664 · COMPLETED

Trial details

NCT number
NCT04811664
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
SARS-CoV-2 Infection
Start date
2021-03-24
Primary completion
2021-12-30
Enrollment
1923

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.